Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy

G Cardillo, Sahar Mokhles, N Williams, F Macbeth, C Russell, T Treasure

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
6 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1636-1636
Number of pages1
JournalBritish Journal of Cancer
Volume113
Issue number11
DOIs
Publication statusPublished - 2015

Research programs

  • EMC COEUR-09

Cite this